Hemispherx Biopharma Announces Commencement of Rights Offering Subscription Period – GlobeNewswire
Hemispherx Biopharma Announces Commencement of Rights Offering Subscription Period GlobeNewswire OCALA, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) — Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma … … Continue reading →